Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00895583 · ClinicalTrials.gov registry record · Phase 4
Study Evaluating A Planned Transition From Tacrolimus To Sirolimus In Kidney Transplant Recipients
A Phase 4 study, sponsored by Pfizer.
- Completed
- Registry status
- Phase 4
- Development phase
- 254
- Enrollment target
NCT00895583 is a Phase 4 study that has completed, run by Pfizer. The registered enrollment target is 254 participants.
The verdict
NCT00895583, a Phase 4 study, has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 254 participants
- Enrollment target
Study Summary
This study will look at the effect on long-term kidney function using tacrolimus right after a transplant and then switching to sirolimus at 3 to 5 months after the transplant.
Interventions
- DRUG Sirolimus
- DRUG Tacrolimus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 254 participants |
| Start Date | 2009-06 |
| Est. Completion | 2013-08 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00895583
The ClinicalTrials.gov registry entry for NCT00895583 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 254 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Sirolimus is the first listed.
NCT00895583 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00895583 about?
NCT00895583 is a clinical study titled "Study Evaluating A Planned Transition From Tacrolimus To Sirolimus In Kidney Transplant Recipients". This study will look at the effect on long-term kidney function using tacrolimus right after a transplant and then switching to sirolimus at 3 to 5 months after the transplant.
What is the current status of trial NCT00895583?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 254 participants. The study started on 2009-06. Estimated completion is 2013-08.
What interventions are being tested in trial NCT00895583?
The interventions under investigation include: Sirolimus (DRUG), Tacrolimus (DRUG).
Who is sponsoring clinical trial NCT00895583?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.